2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $6B | $6.6B | $7.3B | $8.2B | $8.7B |
Cost of Revenue | $3.1B | $3.5B | $3.8B | $4.2B | $4.5B |
Gross Profit | $2.9B | $3.2B | $3.5B | $4B | $4.3B |
Gross Profit % | 49% | 48% | 48% | 48% | 49% |
R&D Expenses | $0.086 | $0.092 | $0.11 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $370M | $500M | $705M | $969M | $814M |
Dep. & Amort. | $1.4B | $1.7B | $1.7B | $1.8B | $2B |
Def. Tax | $152M | $104M | $0 | $0 | $0 |
Stock Comp. | $295M | $364M | $404M | $408M | $462M |
Chg. in WC | $32M | -$133M | $26M | -$75M | -$340M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.6B | $1.5B | $1.9B | $2.1B | $3.1B |
ST Investments | $4.5M | $117M | $106M | $0 | $527M |
Cash & ST Inv. | $1.6B | $1.5B | $1.9B | $2.1B | $3.6B |
Receivables | $690M | $935M | $1.1B | $1.3B | $949M |
Inventory | $0 | $276M | $84M | $1 | $0 |
EQIX reported Q4 revenues of $2.261 billion, up 7% year-over-year on a normalized and constant currency basis, with adjusted EBITDA of $1.021 billion, representing 45% of revenues.
The company recorded a $73 million impairment charge for its Hong Kong asset and a $31 million restructuring charge related to workforce reductions, aimed at improving return on invested capital.
For 2025, EQIX expects revenue growth of 7%-8% and adjusted EBITDA margin improvement of 190 basis points, driven by recurring revenue growth and operational efficiencies.
EQIX is accelerating capacity additions, with 62 major projects underway, including expansions in key markets like NY3, DC16, and LD4, to address capacity constraints and meet strong customer demand.
The company remains optimistic about AI-related demand, with 50% of its top 25 Q4 deals tied to high-performance compute workloads, and plans to triple its XScale business by 2027 to capture hyperscale opportunities.